Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Auxilium Pharmaceuticals (AUXL)

Add to Watchlists
Create an Alert
27.53 -1.19  -4.14% NASDAQ Apr 23, 8:00PM BATS Real time Currency in USD
View Full Chart
AUXL Price Chart
View All Events

AUXL Events

Date Type Description
Feb 28 Misc Auxilium Pharmaceuticals, Inc. Q4 2013 Earning Conference Call
Feb 28 Earnings Auxilium Pharmaceuticals, Inc. Q4 2013 Earning Result. Estimate: 0.15.
Nov 06 Misc Auxilium Pharmaceuticals, Inc. Q3 2013 Earnings Conference Call
Nov 06 Earnings Auxilium Pharmaceuticals, Inc. Q3 2013 Earnings Release. Estimate: 0.05.
Aug 01 Earnings Q2 2013 Auxilium Pharmaceuticals, Inc. Earnings. Estimate: -0.08.
Aug 01 Misc Q2 2013 Auxilium Pharmaceuticals, Inc. Earnings Conference Call
May 01 Misc AGM Event for Auxilium Pharmaceuticals Inc
Apr 29 Misc Q1 2013 Auxilium Pharmaceuticals, Inc. Earnings Conference Call
Apr 29 Earnings Auxilium Pharmaceuticals to Announce First Quarter 2013 Results. Estimate: 0.05.
View All Performance Charts

AUXL Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Auxilium Pharmaceuticals is up 66.55% over the last year vs S&P 500 Total Return up 22.59%, Forest Laboratories up 153.7%, and Shire up 80.34%.

Get Quote for

PDF Report for AUXL

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download AUXL Pro Report PDF
Advertisement

Portfolio Strategies Featuring AUXL

Did Auxilium Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

AUXL Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Headquarters Country: United States
  • Headquarters State/Province: Pennsylvania
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Auxilium Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company primarily in the United States. It focuses on developing and marketing products to urologists, endocrinologists, primary care physicians, hand surgeons, and rheumatologists, as well as to orthopedic, general, and plastic surgeons. The company has a strategic alliance with Asahi Kasei Pharma Corporation for the development, commercialization, and supply of XIAFLEX, a biologic for the treatment of Dupuytren’s contracture and Peyronie’s disease. Auxilium Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Malvern, Pennsylvania.

Recent Quotes

Symbol Price Chg Chg % Market Cap
AUXL 27.53 -1.19 -4.14% 1.370B
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.